| 标题 |
 Abstract CT116: BMS-986205, an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic (PD) activity, alone and in combination with nivolumab (nivo) in advanced cancers in a phase 1/2a trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Cancer Research 作者：Lillian L. Siu; Karen Gelmon; Quincy Chu; Russell Pachynski; Olatunji Alese; et al 出版日期：2017 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
嘻嘻哈哈
OK
lili
迷人的天抒
学术文献互助
不潮薯饼
竹青
路豐遙
GingerF
Raftaar
Criminology34
haijun
LL
skearthy
Nole
星野
清平道人
MchemG
皖公网安备34019202002308
